财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(CANF)
公司资讯
finviz | 2022年09月23日 20:00
Can-Fite BioPharma Ltd. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
finviz | 2022年09月12日 19:00
Can-Fite: New Phase III Psoriasis Data Showing Superior Safety & Improved Efficacy Presented by KOL Dr. Papp at the 31st European Academy of Dermatology
finviz | 2022年08月25日 19:00
Can-Fite Reports Second Quarter 2022 Financial Results & Provides Clinical Update
finviz | 2022年08月23日 19:00
Can-Fites Drug Namodenoson Approved for Compassionate Use Treatment of Advanced Liver Cancer Patients in Romania
finviz | 2022年08月22日 19:00
Can-Fite Selected to Present the Positive Psoriasis Phase III Data at the 31st European Academy of Dermatology and Venerology Congress
finviz | 2022年08月17日 19:25
Can-Fite: Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix
finviz | 2022年07月11日 19:00
Can-Fite to Submit FDA & EMA Registration Plans for Piclidenoson in the Oral Treatment of Moderate to Severe Psoriasis
finviz | 2022年06月29日 19:46
Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial
finviz | 2022年06月29日 19:00
Can-Fite Announces Positive Top-Line Results from Piclidenoson Phase III COMFORT Study in Moderate to Severe Psoriasis
finviz | 2022年06月24日 19:00
Can-Fites CF602 Reverses Erectile Dysfunction in Diabetic Pre-clinical Model: Study Published in Peer-Reviewed Journal Andrologia
finviz | 2022年06月09日 19:00
Can-Fite Announces Publication of Clinical Study Data for Piclidenoson and Namodenoson in Scientific Journal
finviz | 2022年05月26日 19:00
Can-Fite Reports First Quarter 2022 Financial Results & Provides Clinical Update
finviz | 2022年05月16日 19:00
Can-Fite Granted Key NASH Patent in Israel
finviz | 2022年05月02日 19:00
Can-Fites CEO to Present Namodenosons Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit
finviz | 2022年04月05日 19:00
Can-Fite is Developing a Topical Piclidenoson Psoriasis Treatment that Shows Efficacy in a Preclinical Model: Potential Complementary Product to its Phase III Oral Psoriasis Drug
finviz | 2022年03月28日 19:00
Can-Fite to Present at Dermatology Drug Development Summit Europe on April 6, 2022
首页  上页
下页